Frank J. Fabio
Directeur Financier/CFO chez CERES VENTURES, INC.
Profil
Frank J.
Fabio is currently the Chief Financial Officer at Ceres Ventures, Inc. He previously held the position of Chief Financial Officer & Secretary at RenovaCare, Inc., NDB Energy, Inc., and SolarWindow Technologies, Inc. He also served as Interim Chief Financial Officer & Secretary at HepaLife Technologies, Inc. Fabio received his graduate degree from Long Island University in 1989 and his undergraduate degree from Pace University in 1973.
Postes actifs de Frank J. Fabio
| Sociétés | Poste | Début |
|---|---|---|
| CERES VENTURES, INC. | Directeur Financier/CFO | 29/04/2013 |
Anciens postes connus de Frank J. Fabio
| Sociétés | Poste | Fin |
|---|---|---|
NDB Energy, Inc.
 NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Directeur Financier/CFO | 09/01/2009 |
| RENOVACARE, INC. | Directeur Financier/CFO | 09/01/2009 |
| SOLARWINDOW TECHNOLOGIES, INC. | Directeur Financier/CFO | 09/01/2009 |
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Directeur Financier/CFO | 14/11/2007 |
Formation de Frank J. Fabio
| Pace University | Undergraduate Degree |
| Long Island University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| RENOVACARE, INC. | Health Technology |
| SOLARWINDOW TECHNOLOGIES, INC. | Producer Manufacturing |
| CERES VENTURES, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Finance |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
